FLGT Fulgent Genetics, Inc.
$21.52▲ +3.96%
Healthcare
Other
Volume 397.6K
Avg Volume (10D) 256.9K
Key Metrics & Fundamentals
Market Cap
$592.13M
P/E Ratio
–
Div Yield
0.00%
52W Range
13.46 - 31.04
% vs 50 MA
3.88%
% vs 200 MA
10.69%
RSI-14
57.0
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.84
Free Cash Flow
-$27.62M
Gross Rev
$85.39M
Gross Profit
$25.68M
EBITDA
-$19.78M
COGS
$59.71M
Operating Exp
$59.58M
Operating Income
-$33.90M
EBIT
-$33.90M
Pretax Income
-$29.69M
Net Income
-$29.53M
EPS (Diluted)
-1.05
Price & Volume History
Loading chart…
Recent News
How Long Can GeneDx Keep Burning Cash?
Trefis · Oct 21, 2026 12:23 PM ET
Fulgent to Announce Third Quarter 2026 Financial Results on Thursday, November 5, 2026
Business Wire · Oct 15, 2026 4:05 PM ET
PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now?
Zacks · Sep 22, 2026 1:16 PM ET
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 7, 2026 10:14 PM ET
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets
Simply Wall St. · Aug 6, 2026 2:09 AM ET
Fulgent Genetics, Inc. Q2 2026 Earnings Call Summary
Moby · Jul 31, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See FLGT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.